
|Articles|August 23, 2022
Daily Medication Pearl: Seizalam
Author(s)Saro Arakelians, PharmD
Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults.
Advertisement
Medication Pearl of the Day: Midazolam injection (Seizalam)
Indication: Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults.
Insight:
- Dosing: Injection: 50 mg/10 mL (5 mg/mL) in a multiple-dose vial.
- Dosage forms: The recommended dose is 10 mg, administered by intramuscular injection.
- Adverse events: The most common adverse reactions (incidence >3%) in clinical trials in patients with status epilepticus were upper airway obstruction, agitation, and pyrexia.
- Mechanism of action: The exact mechanism of action for midazolam in the treatment of status epilepticus is not fully understood but is thought to involve potentiation of GABAergic neurotransmission resulting from binding at the benzodiazepine site of the GABAA receptor.
Source:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
2
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
3
Darovasertib Plus Crizotinib Shows Striking Efficacy in HLA-A2–Negative Metastatic Uveal Melanoma, OptimUM-02 Results Show
4
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
5








































































































































